For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20231110:nRSJ0080Ta&default-theme=true
RNS Number : 0080T Cambridge Nutritional Sciences PLC 10 November 2023
Cambridge Nutritional Sciences plc
(the 'Company' or 'CNS')
Warrant Expiry
and
Block Admission Cancellation
Cambridge Nutritional Sciences plc (AIM: CNSL), the specialist medical
diagnostics company focused on promoting a personalised and functional
approach to health and nutrition, announces that all warrants issued
alongside its capital raise announced 6 May 2022 have now expired
("Warrants").
Further to the above the Company has made application to AIM to cancel the
Company's Block Admission, which was originally established to facilitate the
issuance of ordinary shares following receipt of any exercise of the Warrants
(the "Cancellation"). The Cancellation will become effective Monday 13
November, as such no further interim returns will be published in relation to
the Company's Block Admission. The Balance of ordinary shares under the Block
Admission not issued/allotted at the time of Cancellation is 90,000,000.
Contacts:
Cambridge Nutritional Sciences plc www.cnsplc.com (http://www.cnsplc.com)
Jag Grewal, Chief Executive Officer via Walbrook PR
Cavendish Capital Markets Limited Tel: 020 7220 0500
Geoff Nash / Edward Whiley / George Dollemore (Corporate Finance)
Nigel Birks / Harriet Ward (ECM)
Walbrook PR Limited Tel: 020 7933 8780 or CNS@walbrookpr.com (mailto:CNS@walbrookpr.com)
Paul McManus / Charlotte Edgar Mob: 07980 541 893 / 07884 664 686
Sam Allen Mob: 07502 558 258
About Cambridge Nutritional Sciences plc
Cambridge Nutritional Sciences plc (AIM: CNSL) is a specialist medical
diagnostics company focused on industry-leading Health and Nutrition products.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END MSCKZMGMNLGGFZM